Mitomycin C + high-dose medroxyprogesterone versus cyclophosphamide+doxorubicin plus fluorouracil as first-line treatment for metastatic breast cancer.

Saved in:
Bibliographic Details
Title: Mitomycin C + high-dose medroxyprogesterone versus cyclophosphamide+doxorubicin plus fluorouracil as first-line treatment for metastatic breast cancer.
Authors: Falkson CI; Department of Medical Oncology, University of Pretoria, South Africa., Falkson G, Falkson CB, Falkson HC
Source: Oncology [Oncology] 1992; Vol. 49 (6), pp. 418-21.
Publication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Karger Country of Publication: Switzerland NLM ID: 0135054 Publication Model: Print Cited Medium: Print ISSN: 0030-2414 (Print) Linking ISSN: 00302414 NLM ISO Abbreviation: Oncology Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:0030-2414
DOI:10.1159/000227084